Stay updated with breaking news from Qdenga. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Japanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase its manufacturing capacity to up to 50 million doses a year, supporting Takeda s goal to produce 100 million doses annually by 2030. The collaboration leverages Takeda s existing facility in Germany and its partnership with IDT Biologika GmbH. ....
India Business News: Takeda and Biological E Limited have partnered to manufacture up to 50 million doses per year of the dengue vaccine QDENGA, with the goal of deliverin ....
PETALING JAYA: The Health Ministry should consider approving a newly released dengue vaccine to combat the ever-increasing number of cases in the country, says Datuk Dr Lam Sai Kit. ....